Oxidative modification of low-density lipoprotein: Lipid peroxidation by myeloperoxidase in the presence of nitrite

Biological Chemistry

Volumn 385, Issue 9, 2004, Pages 809-818

  Kraemer, Tilo ^a   Prakosay, Inthanongsack ^a   Date, Rahul A ^a   Sies, Helmut ^a   Schewe, Tankred ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antioxidant; Atherosclerosis; Cocoa; Epicatechin; Flavonoids; LDL oxidation; Procyanidins

Indexed keywords

ALKADIENE; CHLORIDE; COPPER ION; EPICATECHIN; FLAVAN DERIVATIVE; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; NITRITE; PEROXYNITRITE; TYROSINE;

ARTERY WALL; ARTICLE; ATHEROGENESIS; CACAO; CARDIOVASCULAR SYSTEM; CONCENTRATION (PARAMETERS); CONJUGATION; CONTROLLED STUDY; ENZYME REPRESSION; LIPID PEROXIDATION; NITRATION; OLIGOMERIZATION; OXIDATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN MODIFICATION; REACTION ANALYSIS; STIMULATION;

DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; NITRITES; OXIDATIVE STRESS; PEROXIDASE;

THEOBROMA CACAO;

EID: 5044238300     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2004.106     Document Type: Article

References (51)

1. Baldus, S., Eiserich, J.P., Mani, A., Castro, L., Figueroa, M., Chumley, P., Ma, W., Tousson, A., White, C.R., Bullard, D.C. et al. (2001). Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J. Clin. Invest. 108, 1759-1770.
2. Berliner, J.A., and Heinecke, J.W. (1996). The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20, 707-727.
3. Bligh, E, and Dyer, W. (1959). A rapid method of total lipid extraction and purification. Can. J. Biochem. 37, 911-917.
4. Brennan, M.-L., Anderson, M.M., Shih, D.M., Qu, X., Wang, X., Mehta A.C., Lim, L.L., Shi, W., Hazen, S.L., Jacob, J.S. et al. (2001). Increased atherosclerosis in myeloperoxidase-deficient mice. J. Clin. Invest. 107, 419-430.
5. Brennan, M.-L., Wu, W., Fu, X., Shen, Z., Song, W., Frost, H., Vadseth, C., Narine, L., Lenkiewicz, E., Borchers, M.T. et al. (2002). A tale of two controversies. Defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J. Biol. Chem. 277, 17415-17427.
6. Brennan, M.-L., Penn, M.S., van Lente, F., Nambi, V., Shishebor, M.H., Aviles, R.J., Goormastic, M., Pepoy, M.L., McErlean, E.S., Topol, E.J. et al. (2003). Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med. 349, 1595-1604.
7. Burner U., Krapfenbauer, G., Furtmüller, P.G., Regelsberger, G., and Obinger, C. (2000a) Oxidation of hydroquinone, 2,3-dimethylhydroquinone and 2,3,5-trimethylhydroquinone by human myeloperoxidase. Redox Rep. 5, 185-190.
8. Burner, U., Furtmüller, P.G., Kettle, A.J., Koppenol, W.H., and Obinger, C. (2000b). Mechanism of reaction of myeloperoxidase with nitrite. J. Biol. Chem. 275, 20597-20601.
9. Buyn, J., Mueller, D.M., Fabjan, J.S., and Heinecke, J.W. (1999). Nitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide-nitrite system promotes lipid peroxidation of low density lipoprotein. FEBS Lett. 455, 243-246.
10. --mediated modification of low density lipoprotein. J. Biol. Chem. 276, 1822-1828.
11. Carr, A.C., McCall, M.R., and Frei, B. (2000a). Oxidation of LDL by myeloperoxidase and reactive nitrogen species. Reaction pathways and antioxidant protection. Arterioscler. Thromb. Vasc. Biol. 20, 1716-1723.
12. Carr, A.C., Myzak, M.C., Stocker, R., McCall, M.R., and Frei, B. (2000b). Myeloperoxidase binds to low-density lipoprotein; potential implications for atherosclerosis. FEBS Lett. 487, 176-180.
13. Chisolm, G.M., and Steinberg, D. (2000). The oxidative modification hypothesis of atherogenesis: an overview. Free Radic. Biol. Med. 28, 1815-1826.
14. Daugherty, A., Dunn, J.L., Rateri, D.L., and Heinecke, J.W. (1994). Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94, 437-444.
15. Diniz, T.C.P., Santos, C.L., and Almeida, L.M. (2002). The apoprotein is the preferential target for peroxynitrite-induced LDL damage protection by dietary phenolic acids. Free Radic. Biol. Med. 36, 531-543.
16. Eiserich, J.P., Baldus, S., Brennan, M.-L., Ma, W., Zhang, C., Tousson, A., Castro, L., Lusis, A.J., Nauseef, W.M., White, C.R., and Freeman, B.A. (2002). Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296, 2391-2394.
17. El-Saadani, M., Esterbauer, H., El-Sayed, M., Goher, M., Nasser, A.Y., and Jürgens, G. (1989). A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30, 627-630.
18. Furtmüller, P.G., Burner, U., Jantschko, W., Regelsberger, G., and Obinger, C. (2000). Two-electron reduction and one-electron oxidation of organic hydroperoxides by human myeloperoxidase. FEBS Lett. 484, 139-143.
19. Galijasevic, S., Saed, G.M., Diamond, P.P., and Abu-Soud, H.M. (2003). Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition. Proc. Natl. Acad. Sci. USA 100, 14766-14771.
20. Gavino, V.C., Miller, J.S., Ikharebha, S.O., Milo, G.E., and Cornwell, D.G. (1981). Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures. J. Lipid Res. 22, 763-769.
21. Hammerstone, J.F., Lazarus, S.A., Mitchell, A.E., Rucker, R., and Schmitz, H.H. (1999). Identification of procyanidins in cocoa (Theobroma cacao) and chocolate using high-performance liquid chromatography/mass spectrometry. J. Agric. Food Chem. 47, 490-496.
22. Hazen, S.L., and Heinecke, J.W. (1997). 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99, 2075-2081.
23. Heinecke, J.W. (1997). Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 141, 1-15.
24. Kleinveld, H.A., Hak-Lemmers, H.L., Stalenhoef, A.F., and Demacker, P.N. (1992). Improved measurement of low-density lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin. Chem. 38, 2066-2072.
25. Koppenol, W.H., Kissner, R., and Beckman, J.S. (1996). Synthesis of peroxynitrite: To go with the flow or on solid grounds? Methods Enzymol. 269, 296-302.
26. Kostyuk, V.A., Kraemer, T., Sies, H., and Schewe, T. (2003). Myeloperoxidase/nitrite-mediated lipid peroxidation of low-density lipoprotein as modulated by flavonoids. FEBS Lett. 537, 146-150.
27. Lee, K.W., Kim, Y.J., Lee, H.J., and Lee, C.Y. (2003). Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J. Agric. Food Chem. 51, 7292-7295.
28. Leeuwenburgh, C., Hardy, M.M., Hazen, S.L., Wagner, P., Ohishi, S., Steinbrecher, U.P., and Heinecke, J.W. (1997a). Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272, 1433-1436.
29. Leeuwenburgh, C., Rasmussen, J.E., Hsu, F.F., Mueller, D.M., Pennathur, S., and Heinecke, J.W. (1997b). Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272, 3520-3526.
30. Luoma, J.S., Stralin, P., Marklund, S.L., Hiltunen, T.P., Sarkioja, T., and Ylä-Herttuala, S. (1998). Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler. Thromb. Vasc. Biol. 18, 157-167.
31. Lusis, A.J. (2000). Atherosclerosis. Nature 407, 233-241.
32. Maron, D.J. (2004). Flavonoids for reduction of atherosclerotic risk. Curr. Atheroscler. Rep. 6, 73-78.
33. Mathur, S., Devaraj, S., Grundy, S.M., and Jialal, I. (2002). Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans. J. Nutr. 132, 3663-3667.
34. Panasenko, O.M., Briviba, K., Klotz, L.-O., and Sies, H. (1997). Oxidative modification and nitration of human low-density lipoproteins by the reaction of hypochlorous acid with nitrite. Arch. Biochem. Biophys. 343, 254-259.
35. Podrez, E.A., Febbraio, M., Sheibani, N., Schmitt, D., Silverstein, R.L., Hajjar, D.P., Cohen, P.A., Frazier, W.A., Hoff, H.F., and Hazen, S.L. (2000). Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J. Clin. Invest. 105, 1095-1108.
36. Podrez, E.A., Schmitt, D., Hoff, H.H., and Hazen S.L. (1999). Myeloperoxidase-generated reactive nitrogen species convert LDL in its atherogenic form in vitro. J. Clin. Invest. 103, 1547-1560.
37. Radi, R. (2004). Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. USA 101, 4003-4008.
38. Rodriguez, J., Maloney, R.E., Rassaf, T., Bryan, N.S., and Feelisch M. (2003). Chemical nature of nitric acid storage forms in rat vascular tissues. Proc. Natl. Acad. Sci. USA 100, 336-341.
39. Rubbo, H., Trostchansky, A., Botti, H., and Batthyány, C. (2002). Interactions of nitric oxide and peroxynitrite with low-density lipoprotein. Biol. Chem. 383, 547-552.
40. Savenkova, M.I., Mueller, D.M., and Heinecke, J.W. (1994). Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 296, 20394-20401.
41. Schmitt, D., Shen, Z., Zhang, R., Colles, S.M., Wu, W., Salomon, R.G., Chen, Y., Chisolm, G.M., and Hazen, S.L. (1999). Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum. Biochemistry 38, 16904-16915.
42. Schroeder, P., Klotz, L.-O., Buchczyk, D.P., Sadik, C.D., Schewe, T., and Sies, H. (2001). Epicatechin selectively prevents nitration but not oxidation reactions of peroxynitrite. Biochem. Biophys. Res. Commun. 285, 782-787.
43. Steinberg, D.S., Parthasarathy, T.E., Carew, J.C., Khoo, and Witztum, J.L. (1989). Beyond cholesterol. Modification of low density lipoprotein that increases its atherogenicity. N. Engl. J. Med. 320, 915-924.
44. Steinberg, F.M., Bearden, M.M., and Keen, C.L. (2003). Cocoa and chocolate flavonoids: implications for cardiovascular health. J. Am. Diet. Assoc. 103, 215-223.
45. Turko, I.V., and Murad, F. (2002). Protein nitration in cardiovascular diseases. Pharmacol. Rev. 54, 619-634.
46. Ursini, F., and Sevanian, A. (2002). Postprandial oxidative stress. Biol. Chem. 383, 599-605.
47. van Dalen, C.J., Winterbourn, C.C., Senthilmohan, R., and Kettle, A.J. (2000). Nitrite as a substrate and inhibitor of myeloperoxidase. Implication for nitration and hypochlorous acid production at sites of inflammation. J. Biol. Chem. 275, 11638-11644.
48. van der Vliet, A., Eiserich, J.P., Halliwell B., and Cross, C.E. (1997). Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J. Biol. Chem. 272, 7617-7625.
49. Winterbourn, C.C., Vissers, M.C., and Kettle A.J. (2000). Myeloperoxidase. Curr. Opin. Hematol. 7, 53-58.
50. Zhang, H.F., Davis, W.B., Chen, X.S., Whisler, R.L., and Cornwell, D.G. (1989). Studies on oxidized low density lipoproteins. Controlled oxidation and a prostaglandin artifact J. Lipid Res. 30, 141-148.
51. Zhang, R., Brennan, M.-L., Shen, Z., MacPherson, J.C., Schmitt, D., Molenda, C.E., and Hazen S.L. (2002). Myeloperoxidase functions as major catalyst for initiation of lipid peroxidation at sites of inflammation. J. Biol. Chem. 277, 46116-46122.